Trending Now
ZenaTech, Inc. (ZENA): Revolutionizing Defense and Enterprise Solutions with NDAA-Compliant AI...
ZenaTech, Inc. (Nasdaq: ZENA), a leader in AI-powered drone solutions and enterprise SaaS platforms, has taken a monumental step forward in its...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Momentum Stocks Catch Fire as Market Boils (AMC, FCEL, CMGR, MMEDF)
In case you haven’t noticed, the stock market is making your neighbor rich. Feel bad yet? He just bought another sports car...
MAKE IT MODERN
LATEST REVIEWS
ISW Holdings Inc (OTCMKTS:ISWH) Bets on High-Growth Diversification
In building the case for diversified small caps, such as ISW Holdings Inc (OTCMKTS:ISWH), you have to paint a picture that shows credible promise...
MAKE IT MODERN
PERFORMANCE TRAINING
Denison Mines Corp (NYSEAMERICAN: DNN) Gains 50% Ownership of JCU for $41 Million in...
Denison Mines Corp (NYSEAMERICAN: DNN) has gained 50% ownership of JCU Exploration Company. It is pretty excited to complete the acquisition, paying $20.5 million...
Codexis Inc. (NASDAQ: CDXS) Enters Licensing and Manufacturing partnership With Almelo Private Ltd and...
Codexis Inc. (NASDAQ: CDXS) has entered a tri-party partnership agreement with Indian active pharmaceutical ingredients (APIs) producer Almelo Private Ltd. and US-based pharmaceutical manufacturing...
Clean Energy Stocks on Sale and What to Do About It (CLNE, VKIN, NEE,...
As growth stocks sell off, investors have the opportunity to gain exposure to the secular narrative around clean energy, which is destined...
Ionis Pharmaceutical Inc.’s (NASDAQ: IONS) Partner, Roche Designs New Phase II Tominersen in Huntington...
Ionis Pharmaceutical Inc. (NASDAQ: IONS) has revealed that its partner, Roche, is designing a new second phase study assessing tominersen Huntington's disease. Tominersen could...
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Lays Off A Section Of Its Workforce
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) has been a front runner among companies focusing on dealing with the treatment of NASH for years. A quarter of...
MAKE IT MODERN
